कृपया अन्य खोज का प्रयास करें
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Claude Bertrand | 61 | 2014 | Member of Scientific Advisory Board |
Christian Trepo | - | - | Member of Scientific Advisory Board |
Christoph Hubert Huber | 79 | - | Member of Scientific Advisory Board |
Luc Teyton | - | - | Member of Scientific Advisory Board |
Lawrence R. Stanberry | - | - | Member of Scientific Advisory Board |
Ian McGowan | - | 2018 | Chairman of Scientific Advisory Board |
June H. Lee | 57 | 2023 | Independent Director |
Troy A. Ignelzi | 55 | 2023 | Independent Director |
Christian Brechot | 70 | 2017 | Member of Scientific Advisory Board |
Corinna Zur Bonsen-Thomas | - | 2017 | Independent Non-Executive Director |
Carol L. Brosgart | 71 | 2018 | Independent Non-Executive Director |
Kinam Hong | - | 2019 | Non-Executive Director |
Jurgen Rockstroh | - | 2018 | Member of Scientific Advisory Board |
Camilla Soenderby | 52 | 2024 | Independent Director |
Philippe Pouletty | 66 | 2013 | Founder & Director |
Marc M. P. de Garidel | 66 | 2023 | CEO & Interim Chair of Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है